A Substantial Equivalence Study of RD04723 and Predicate Device
Not Applicable
- Conditions
- Hypertrophic ScarKeloid Scar
- Interventions
- Device: RD047-023Device: Predicate Device
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Oculus Innovative Sciences, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01736969
- Locations
- 🇺🇸
DermResearch Inc, Austin, Texas, United States
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
Phase 2
Completed
- Conditions
- Atopic DermatitisPruritus
- Interventions
- Device: RD047-26
- First Posted Date
- 2010-11-02
- Last Posted Date
- 2012-05-30
- Lead Sponsor
- Oculus Innovative Sciences, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT01232985
- Locations
- 🇺🇸
Dermatology Consulting Services, High Point, North Carolina, United States
Pilot Study of the Safety and Clinical Efficacy of Topical Dermacynâ„¢ Wound Care to Treat Mild Diabetic Foot Infections
Phase 2
Completed
- Conditions
- Foot Ulcer, Diabetic
- Interventions
- Drug: Topical Saline and LevofloxacinDrug: Topical DermacynDrug: Topical Dermacyn and Levofloxacin
- First Posted Date
- 2007-08-16
- Last Posted Date
- 2008-01-14
- Lead Sponsor
- Oculus Innovative Sciences, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT00516958
© Copyright 2025. All Rights Reserved by MedPath